4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-034697
Director acquired 18,002 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brege Laura Director | 2021-06-22 | Option exercise | +3,059 | 3,059 | D | ||
| Brege Laura Director | 2022-06-07 | Option exercise | +6,391 | 9,450 | D | ||
| Brege Laura Director | 2023-06-01 | Option exercise | +8,552 | 18,002 | D | ||
| Derivatives | |||||||
| Brege Laura Director | 2021-06-22 | Option exercise · Restricted Stock Units | −3,059 | 0 | D | ||
| Brege Laura Director | 2022-06-07 | Option exercise · Restricted Stock Units | −6,391 | 0 | D | ||
| Brege Laura Director | 2023-06-01 | Option exercise · Restricted Stock Units | −8,552 | 0 | D | ||
| Brege Laura Director | 2023-06-01 | Grant or award · Director Stock Options (Right to Buy) | +11,045 | 11,045 | D | ||
| Brege Laura Director | 2023-06-01 | Grant or award · Restricted Stock Units | +6,652 | 6,652 | D | ||
Loading xslF345X04/doc4.xml…